Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy of malignant melanoma.

× No keyword cloud information.

20 in total

Review 1. Antineoplastic drugs in 1990. A review (Part II).

Authors: D J Black; R B Livingston
Journal: Drugs Date: 1990-05 Impact factor: 9.546

2. Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy.

Authors: A I Einzig; L M Schuchter; A Recio; S Coatsworth; R Rodriquez; P H Wiernik
Journal: Med Oncol Date: 1996-06 Impact factor: 3.064

3. Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma.

Authors: N H Mulder; D T Sleijfer; E G de Vries; H Schraffordt Koops; P H Willemse
Journal: J Cancer Res Clin Oncol Date: 1990 Impact factor: 4.553

Review 4. Chemotherapy of malignant melanoma.

Authors: R S Benjamin
Journal: World J Surg Date: 1979-07-30 Impact factor: 3.352

Review 5. Temperature and host defense.

Authors: N J Roberts
Journal: Microbiol Rev Date: 1979-06

Review 6. Regional treatment strategies for in-transit melanoma metastasis.

Authors: Ryan S Turley; Amanda K Raymond; Douglas S Tyler
Journal: Surg Oncol Clin N Am Date: 2011-01 Impact factor: 3.495

7. Carboplatinum and cytosine arabinoside in patients with disseminated malignant melanoma. A phase II study.

Authors: B Jeremic; L Djuric; L Mijatovic
Journal: Invest New Drugs Date: 1991-08 Impact factor: 3.850

8. Treatment of advanced malignant melanoma with coumarin and cimetidine: a pilot study.

Authors: M E Marshall; K Butler; J Cantrell; C Wiseman; L Mendelsohn
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

9. Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma.

Authors: D A Amato; H Bruckner; D Guerry; A Ash; G Falkson; E C Borden; R H Creech; E D Savlov; T J Cunningham
Journal: Invest New Drugs Date: 1987 Impact factor: 3.850

10. Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.

Authors: P J Frosch; B M Czarnetzki; E Macher; E Grundmann; I Gottschalk
Journal: J Cancer Res Clin Oncol Date: 1979 Impact factor: 4.553